Advertisement
Screener

LIGAND PHARMACEUTICALS INCORPORATED (LGND) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share

2.4 / 5 stars · 57/120 Roast Me

LIGAND PHARMACEUTICALS INCORPORATED Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share

LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share of $0.00 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.

Financial Statements › Income Statement › Net Income

us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare · last filed 2026-02-27

  • LIGAND PHARMACEUTICALS INCORPORATED income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2024-09-30 was $0.00.
  • LIGAND PHARMACEUTICALS INCORPORATED income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2024-06-30 was $0.00.
  • LIGAND PHARMACEUTICALS INCORPORATED income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2024-03-31 was $0.00.
  • LIGAND PHARMACEUTICALS INCORPORATED income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for the quarter ending 2023-09-30 was $0.00.
  • LIGAND PHARMACEUTICALS INCORPORATED income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2025 was $0.00.
  • LIGAND PHARMACEUTICALS INCORPORATED income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2024 was $0.00.
  • LIGAND PHARMACEUTICALS INCORPORATED income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2023 was -$0.10.
  • LIGAND PHARMACEUTICALS INCORPORATED income (loss) from discontinued operations and disposal of discontinued operations, net of tax, per basic share for fiscal 2022 was -$1.67.
Period endIncome (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 3 monthIncome (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 6 monthIncome (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 6 month as first filedIncome (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 9 monthIncome (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 12 monthIncome (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share 12 month as first filed
2025-12-31$0.00
10-K · filed 2026-02-27
2024-12-31$0.00
10-K · filed 2026-02-27
2024-09-30$0.00
10-Q · filed 2024-11-08
$0.00
10-Q · filed 2024-11-08
2024-06-30$0.00
10-Q · filed 2024-08-07
$0.00
10-Q · filed 2024-08-07
2024-03-31$0.00
10-Q · filed 2024-05-08
2023-12-31-$0.10
10-K · filed 2026-02-27
2023-09-30$0.00
10-Q · filed 2024-11-08
-$0.10
10-Q · filed 2024-11-08
2023-06-30$0.00
10-Q · filed 2024-08-07
-$0.10
10-Q · filed 2024-08-07
2023-03-31-$0.10
10-Q · filed 2024-05-08
2022-12-31-$0.17
10-K · filed 2023-02-28
-$1.67
10-K · filed 2025-02-28
2022-09-30-$0.55
10-Q · filed 2023-11-09
-$1.49
10-Q · filed 2023-11-09
2022-06-30-$0.80
10-Q · filed 2023-08-09
-$0.95
10-Q · filed 2023-08-09
2022-03-31-$0.15
10-Q · filed 2023-05-08
2021-12-31-$0.13
10-K · filed 2023-02-28
-$1.16
10-K · filed 2024-02-29
2021-09-30-$0.40
10-K · filed 2023-02-28
2021-06-30-$0.34
10-K · filed 2023-02-28
2021-03-31-$0.28
10-K · filed 2023-02-28
2020-12-31-$0.59
10-K · filed 2023-02-28
2018-12-31$0.00
10-K · filed 2019-02-28
2017-12-31$0.00
10-K · filed 2019-02-28
2017-09-30$0.00
10-Q · filed 2017-11-09
$0.00
10-Q · filed 2017-11-09
2017-06-30$0.00
10-Q · filed 2017-08-09
$0.00
10-Q · filed 2017-08-09
2017-03-31$0.00
10-Q · filed 2017-05-09
2016-12-31$0.04
10-K · filed 2019-02-28
2016-09-30$0.00
10-Q · filed 2017-11-09
$0.04
10-Q · filed 2017-11-09
2016-06-30$0.00
10-Q · filed 2017-08-09
$0.04
10-Q · filed 2017-08-09
$0.03
10-Q · filed 2016-08-04
2016-03-31$0.04
10-Q · filed 2017-05-09
2015-12-31$0.00
10-K · filed 2018-03-01
2015-09-30$0.00
10-Q · filed 2016-11-14
$0.00
10-Q · filed 2016-11-14
2015-06-30$0.00
10-Q · filed 2016-11-14
$0.00
10-Q · filed 2016-11-14
2015-03-31$0.00
10-Q · filed 2016-11-14
2014-12-31$0.00
10-K · filed 2015-02-23
$0.00
10-K · filed 2017-02-28
$0.13
10-K · filed 2014-12-01
2014-09-30$0.00
10-K · filed 2015-02-23
$0.00
10-Q · filed 2014-10-31
2014-06-30$0.00
10-K · filed 2015-02-23
$0.00
10-Q · filed 2014-08-05
2014-03-31$0.00
10-K · filed 2015-02-23
2013-12-31$0.00
10-K · filed 2015-02-23
$0.13
10-K · filed 2016-11-14
2013-09-30$0.00
10-K · filed 2015-02-23
$0.13
10-Q · filed 2014-10-31
2013-06-30$0.12
10-K · filed 2015-02-23
$0.13
10-Q · filed 2014-08-05
2013-03-31$0.01
10-K · filed 2015-02-23
2012-12-31$0.11
10-K · filed 2015-02-23
2012-09-30$0.19
10-Q · filed 2013-11-08
2012-06-30$0.09
10-Q · filed 2013-08-01
$0.19
10-Q · filed 2013-08-01
2011-12-31$0.00
10-K/A · filed 2014-12-12